¼¼°èÀÇ ¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀå
Monkeypox Testing
»óǰÄÚµå : 1787176
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,229,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,687,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀåÀº 2030³â±îÁö 1¾ï 4,800¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 1¾ï 2,220¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ø¼þÀ̵Îâ °Ë»ç ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 3.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1¾ï 4,800¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ±â¼úÀº CAGR 4.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 8,330¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ãø¸é È帧 ºÐ¼® ±â¼ú ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 2.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3,330¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR6.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀåÀº 2024³â¿¡ 3,330¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 2,960¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.3%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.2%¿Í 2.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.8%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

ÃÖ±Ù ¸î ³â µ¿¾È ¿ø¼þÀ̵Îâ °Ë»ç ¼ö¿ä°¡ ±ÞÁõÇÑ ÀÌÀ¯´Â ¹«¾ùÀϱî?

¼¼°èÀûÀ¸·Î À¯ÇàÇÏ´Â ¿ø¼þÀ̵Îâ·Î ÀÎÇØ ¹ÙÀÌ·¯½º È®»êÀ» ¸·±â À§ÇÑ ½Å¼ÓÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü °Ë»çÀÇ Çʿ伺ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¿ø¼þÀ̵Îâ´Â ¿ø¼þÀ̵Îâ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ¹ß»ýÇÏ´Â ¹ÙÀÌ·¯½º¼º Àμö°øÅëÀü¿°º´À¸·Î ¹ß¿­, ÇǺκ´º¯, ¸²ÇÁÀý ºÎÁ¾ µî õ¿¬µÎ¿Í À¯»çÇÑ Áõ»óÀ» º¸ÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î °¨¿°ÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó °¢±¹ Á¤ºÎ¿Í ÀÇ·á ±â°üÀº °¨¿°À» Á¶±â¿¡ ¹ß°ßÇÏ°í °Ý¸® Á¶Ä¡¸¦ ½ÃÇàÇϱâ À§ÇØ °Ë»ç¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ µµ½Ã³ª Àα¸¹Ðµµ°¡ ³ôÀº Áö¿ª¿¡¼­´Â ¹ÙÀÌ·¯½ºÀÇ Àü¿°¼ºÀÌ ³ô¾Æ Áø´Ü °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹«Áõ»ó ¹× °æÁõ ȯÀÚ°¡ ÃâÇöÇÔ¿¡ µû¶ó ´«¿¡ º¸ÀÌ´Â Áõ»ó ¾øÀ̵µ °¨¿°À» Á¤È®ÇÏ°Ô °¨ÁöÇÒ ¼ö ÀÖ´Â °í°¨µµ ºÐÀÚ °Ë»çÀÇ Çʿ伺ÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ¿©ÇàÀÇ È®´ë¿Í °æÁ¦ÀÇ »óÈ£ ¿¬°áÀº ¿ø¼þÀ̵ÎâÀÇ È®»êÀ» ´õ¿í °¡¼ÓÈ­ÇÏ°í ±¤¹üÀ§ÇÑ °Ë»çÀÇ ±ä±ÞÇÑ Çʿ伺À» Ã˱¸Çϰí ÀÖ½À´Ï´Ù.

¾î¶² ±â¼ú Çõ½ÅÀÌ ¿ø¼þÀ̵Îâ °Ë»ç ´É·ÂÀ» Çâ»ó½Ã۰í Àִ°¡?

÷´Ü Áø´Ü ±â¼úÀÇ °³¹ßÀº ¿ø¼þÀ̵Îâ °Ë»çÀÇ Á¤È®¼º°ú ¼Óµµ Çâ»ó¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(RT-PCR)°ú °°Àº ºÐÀÚ ±â¹Ý ¹æ¹ýÀº ³ôÀº ¹Î°¨µµ¿Í ƯÀ̼ºÀ¸·Î ÀÎÇØ ¿ø¼þÀ̵Î⸦ °ËÃâÇÏ´Â µ¥ ÀÖ¾î Ç¥ÁØÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½Å¼Ó Ç׿ø °Ë»ç ¶ÇÇÑ °íÀ§Ç豺 ´ë»óÀÇ ½Å¼ÓÇÑ ¼±º°°Ë»ç¸¦ À§ÇÑ ÇöÀå Áø·á ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇØ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS)Àº ¹ÙÀÌ·¯½ºÀÇ º¯À̸¦ ÃßÀûÇϰí ÀüÆÄ ÆÐÅÏÀ» ÀÌÇØÇϱâ À§ÇØ È°¿ëµÇ°í ÀÖ½À´Ï´Ù. Áø´Ü µµ±¸¿¡ ÀΰøÁö´É(AI)À» Á¢¸ñÇÏ¿© °Ë»ç °á°ú ÇØ¼®ÀÇ È¿À²¼ºÀ» ´õ¿í Çâ»ó½Ã۰í, ÀÇ·á Àü¹®°¡ÀÇ ¾÷¹« ºÎ´ãÀ» °æ°¨½Ã۰í ÀÖ½À´Ï´Ù. °¡Á¤¿ë °Ë»ç ŰƮµµ Á¢±Ù¼ºÀ» °³¼±Çϰí Ãë¾àÇÑ Áö¿ª»çȸÀÇ ÀÚ°¡ ¸ð´ÏÅ͸µÀ» Àå·ÁÇϱâ À§ÇØ °ËÅäµÇ°í ÀÖ½À´Ï´Ù.

Á¤ºÎÀÇ ±ÔÁ¦¿Í °øÁߺ¸°Ç¿¡ ´ëÇÑ ³ë·ÂÀº ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

¼¼°è °¢±¹ Á¤ºÎ¿Í º¸°Ç ±â°üÀº ¿ø¼þÀ̵Î⠹߻ýÀ» ¾ïÁ¦Çϱâ À§ÇØ ±¤¹üÀ§ÇÑ °Ë»ç Àü·«À» ½ÃÇàÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO), Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(CDC), ±âŸ ¼¼°è º¸°Ç±â°üµéÀº °Ë»ç ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ °¡À̵å¶óÀÎÀ» ¹ßÇ¥ÇÏ°í °Ë»ç ½Ã¼³ ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ È®´ë¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. °¢±¹ Á¤ºÎ´Â ¶ÇÇÑ »õ·Î¿î °Ë»ç ŰƮÀÇ ±ÔÁ¦ ´ç±¹ ½ÂÀÎÀ» ½Å¼ÓÈ÷ ÁøÇàÇÏ¿© ÀÇ·á ȯ°æÀ¸·ÎÀÇ ¹èÆ÷¸¦ °¡¼ÓÈ­Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ß°ú ÀÚ°¡ °Ý¸®¸¦ °­Á¶ÇÏ´Â °øÁߺ¸°Ç Ä·ÆäÀÎÀº Àú·ÅÇÏ°í ±¤¹üÀ§ÇÏ°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °Ë»ç ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̵¿½Ä °Ë»ç ÀåÄ¡¿Í Áö¿ª ±â¹Ý °ËÁø ÇÁ·Î±×·¥ÀÇ È®´ë´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¹ßº´ Áõ°¡, Áø´Ü ±â¼ú ¹ßÀü, Á¤ºÎÀÇ °Ë»ç ÀÌ´Ï¼ÅÆ¼ºê µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â °¨¿°º´ °¨½Ã¸¦ À§ÇÑ ÅõÀÚ Áõ°¡À̸ç, ÀÌ´Â Áø´Ü ½ÇÇè½Ç°ú ½Å¼Ó °Ë»ç ÀÎÇÁ¶óÀÇ È®´ë·Î À̾îÁö°í ÀÖ½À´Ï´Ù. PCR ±â¹Ý °Ë»çÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí, ÈÞ´ë°¡ °£ÆíÇÏ°í ½Å¼ÓÇÑ Ç׿ø °Ë»ç°¡ °³¹ßµÈ °Íµµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø¼þÀ̵Îâ¿Í ±× ÀáÀçÀûÀÎ Àå±âÀû °Ç°­ ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ƯÈ÷ °íÀ§Ç豺 Áý´Ü¿¡¼­ °Ë»ç º¸±ÞÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Ç÷ûÇÐÀû °Ë»ç ¹× °¡Á¤¿ë °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ¾î ½ÃÀå¿¡ »õ·Î¿î ±âȸ°¡ âÃâµÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ Á¶±â ¹ß°ß°ú ºÀ¼â¸¦ ÃÖ¿ì¼± °úÁ¦·Î »ï°í Àֱ⠶§¹®¿¡ ÇâÈÄ ¸î ³â µ¿¾È ¿ø¼þÀ̵Îâ °Ë»ç ½ÃÀåÀº Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

±â¼ú(ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ ±â¼ú, Ãø¸é È帧 ºÐ¼® ±â¼ú, ±âŸ ±â¼ú), ÃÖÁ¾»ç¿ëÀÚ(Áø´Ü½ÇÇè½Ç, º´¿ø ¹× Áø·á¼Ò, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Monkeypox Testing Market to Reach US$148.0 Million by 2030

The global market for Monkeypox Testing estimated at US$122.2 Million in the year 2024, is expected to reach US$148.0 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Polymerase Chain Reaction Technology, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$83.3 Million by the end of the analysis period. Growth in the Lateral Flow Assay Technology segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.3 Million While China is Forecast to Grow at 6.3% CAGR

The Monkeypox Testing market in the U.S. is estimated at US$33.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$29.6 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Monkeypox Testing Market - Key Trends & Drivers Summarized

Why Has the Demand for Monkeypox Testing Surged in Recent Years?

The global outbreak of monkeypox has underscored the critical need for rapid and reliable diagnostic testing to contain the spread of the virus. Monkeypox, a viral zoonotic disease caused by the monkeypox virus, presents symptoms similar to smallpox, including fever, skin lesions, and swollen lymph nodes. With cases rising worldwide, governments and healthcare institutions have ramped up testing efforts to identify infections early and implement isolation measures. The demand for diagnostic testing has increased due to the highly transmissible nature of the virus, especially in urban and high-density population areas. Additionally, the emergence of asymptomatic and mild cases has highlighted the necessity for sensitive molecular tests that can accurately detect infections even in the absence of visible symptoms. The expansion of global travel and interconnected economies has further accelerated the spread of monkeypox, driving the urgent need for widespread testing.

What Technological Innovations Are Enhancing Monkeypox Testing Capabilities?

The development of advanced diagnostic techniques has played a crucial role in improving the accuracy and speed of monkeypox testing. Molecular-based methods such as real-time polymerase chain reaction (RT-PCR) have become the gold standard for detecting monkeypox due to their high sensitivity and specificity. Rapid antigen tests are also being developed to provide point-of-care solutions for quick screening in high-risk populations. Additionally, next-generation sequencing (NGS) is being utilized to track viral mutations and understand transmission patterns. The integration of artificial intelligence (AI) in diagnostic tools has further improved the efficiency of test result interpretation, reducing the workload on healthcare professionals. At-home testing kits are also being explored to increase accessibility and encourage self-monitoring in vulnerable communities.

How Are Government Regulations and Public Health Initiatives Influencing the Market?

Governments and health organizations worldwide have implemented extensive testing strategies to control monkeypox outbreaks, fueling demand for diagnostic solutions. The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other global health agencies have issued guidelines on testing protocols, pushing for increased investment in laboratory infrastructure. Governments have also fast-tracked regulatory approvals for novel testing kits to accelerate deployment in healthcare settings. Public health campaigns emphasizing early detection and self-isolation have contributed to the rising demand for affordable and widely available testing options. The expansion of mobile testing units and community-based screening programs has further bolstered market growth.

What Are the Key Factors Driving Growth in the Monkeypox Testing Market?

The growth in the monkeypox testing market is driven by several factors, including increased global outbreaks, advancements in diagnostic technologies, and government-backed testing initiatives. One of the primary drivers is the rising investment in infectious disease surveillance, which has led to the expansion of diagnostic laboratories and rapid testing infrastructure. The increased adoption of PCR-based testing, coupled with the development of portable and rapid antigen tests, is further fueling market expansion. Additionally, growing awareness about monkeypox and its potential long-term health impacts has encouraged widespread testing, particularly in high-risk populations. The ongoing research into serological and at-home testing solutions is expected to create new opportunities in the market. As healthcare systems continue to prioritize early detection and containment, the monkeypox testing market is poised for significant growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Monkeypox Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Polymerase Chain Reaction Technology, Lateral Flow Assay Technology, Other Technologies); End-Use (Diagnostic Laboratories End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â